Candriam SCA’s MiMedx Group MDXG Stock Holding History

Candriam SCA’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-103,000	Closed	-$884K	–	686
2016 Q3	$884K	Hold	103,000	–	–	0.02%	515
2016 Q2	$822K	Hold	103,000	–	–	0.02%	472
2016 Q1	$895K	Hold	103,000	–	–	0.02%	448
2015 Q4	$965K	Sell	103,000 -25,000	-20%	-$217K	0.03%	386
2015 Q3	$1.24M	Buy	+128,000	New	+$1.35M	0.03%	410

Other funds holding MDXG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MFIMFI

Mesirow Financial Investment Management - Fixed Income Chicago, Illinois $98.4M AUM 13.93% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Candriam SCA's MDXG Position: Q4 2016 in Review

Candriam SCA sold out of MiMedx Group (MDXG) in Q4 2016, closing a stake of 103,000 shares — an estimated $884K sold.

Candriam SCA first reported a position in MDXG in Q3 2015 and held it in 5 quarters. The position peaked at $1.24M in Q3 2015. 185 funds tracked by Wall St. Rank hold MDXG as of Q4 2016.

Candriam SCA reported no remaining MiMedx Group position as of Q4 2016 after selling out during the quarter.
Candriam SCA sold 103,000 MiMedx Group shares in Q4 2016, an estimated $884K.
Candriam SCA first reported a position in MiMedx Group in Q3 2015 and held it in 5 quarters.
Candriam SCA's MiMedx Group position peaked at $1.24M in Q3 2015.
185 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2016.

Based on Candriam SCA's 13F filing for Q4 2016, filed 2 Feb 2017.